We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

32 hedge funds and large institutions have $22.7M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more capital invested

Capital invested by funds: $7.41M → $22.7M (+$15.3M)

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

10% more funds holding

Funds holding: 2932 (+3)

6.67% more ownership

Funds ownership: 4.83%11.51% (+6.7%)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
5
Reduced
8
Closed
7
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$53K

NBP Hedge Fund Activity: Q2 2025 in Review

32 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2025, worth a combined $22.7M — up 207% from $7.41M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NBP positions and 7 closed out — a net gain of 3 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $1.54M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $398K sold.

  • 32 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2025, up from 29 in Q1 2025.
  • Funds reported $22.7M of NovaBridge Biosciences American Depositary Shares stock for Q2 2025, up 207% quarter-over-quarter.
  • 10 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2025 and 7 closed out, a net change of +3 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2025 was Candriam SCA, an estimated $1.54M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2025 was Stonepine Capital Management, an estimated $398K sold.

Based on aggregated 13F filings for Q2 2025.